Skip to content
The EU Pharmaceutical Package is a series of legislative proposals that aims to, among other things, improve access, affordability, and availability of medicinal products […]
Breaking down the EU Pharmaceutical Package: What U.S. companies should know Read More »
On May 21, the 90th Paris assembly for World Organisation for Animal Health (WOAH) announced concern over the dramatic rise in cases of avian
Avian flu vaccine discussed by WOAH general session: the potential of a new pandemic Read More »
The new plan to reform European Union pharmaceutical legislation falls short on data and market protections but includes positive efforts to streamline drug approval
Plan to reform EU pharma law elicits kudos and concerns from BIO experts Read More »
On May 5, 2023, the World Health Organization (WHO) declared an end to the COVID-19 Public Health Emergency of International Concern (PHEIC), which began
WHO ends COVID-19 public health emergency—here’s what to know Read More »
A May 3 report shows that more than a quarter of a billion people faced acute food insecurity last year. This data underlines the
Nearly a quarter billion people are hungry. Can biotech help? Read More »
As the population continues to grow, so too does the demand for food. However, climate change and other environmental factors make producing enough food
Meet the lablab bean – a future climate-resilient hero of food security Read More »
Despite progress from some U.S. trading partners in developing global intellectual property protections that enable innovation, much improvement is needed, according to the Special
USTR calls out countries needing better IP protections in annual report Read More »
American medical device manufacturers are amongst the biggest suppliers to Europe’s medical devices market. EUCOPE’s Leander Vranken breaks down the most recent amendments to
What the EU MDR/IVDR amendments mean for medtech and biotech companies Read More »
On April 25, during the South Korean President’s state visit, the Biotechnology Innovation Organization (BIO) and KoreaBIO signed a bilateral Memorandum of Understanding (MOU)
KoreaBio signs MOU to advance the innovation of biotechnology Read More »
The Inflation Reduction Act was meant to be a step forward in improving the affordability and access to innovative medical treatments, but several provisions
Podcast: The impact of the Inflation Reduction Act and EU pharma package on innovation Read More »
